0001104659-23-073047.txt : 20230621
0001104659-23-073047.hdr.sgml : 20230620
20230620205634
ACCESSION NUMBER: 0001104659-23-073047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEALY JAMES
CENTRAL INDEX KEY: 0001245624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 231027190
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
tm2319284-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-14
0
0001771917
Karuna Therapeutics, Inc.
KRTX
0001245624
HEALY JAMES
SOFINNOVA INVESTMENTS, INC.,
3000 SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
1
0
0
0
0
Common Stock
683
I
By Sofinnova Synergy Master Fund, LP
Common Stock
2023-06-14
4
J
0
400000
0
D
1372441
I
By Sofinnova Venture Partners X, LP
Common Stock
2023-06-14
4
J
0
8025
0
A
8025
I
By Sofinnova Management X, L.P.
Common Stock
32500
D
All shares held by Sofinnova Synergy Master Fund, LP (the "Fund"). Sofinnova Synergy Fund GP, LLC (the "GP"), the general partner of the Fund, may be deemed to have sole voting and dispositive power over these shares, and Dr. James I. Healy and Dr. Eric Delbridge, the managing members of the GP, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Sofinnova Venture Partners X, LP ("SVP X") without consideration to its partners in accordance with the limited partnership agreement of SVP X (the "SVP X Distribution").
All shares held by SVP X. Sofinnova Management X, L.P. ("SM X LP"), the general partner of SVP X, may be deemed to have sole voting and dispositive power over these shares, and Sofinnova Management X-A, L.L.C. ("SM X LLC"), the general partner of SM X LP, may be deemed to have sole voting and dispositive power over these shares. Dr. James I. Healy and Dr. Maha Katabi, the managing members of SM X LLC, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
Shares acquired by SM X LP in connection with the SVP X Distribution reported above.
All shares held by SM X LP. SM X LLC, the general partner of SM X LP, may be deemed to have sole voting and dispositive power over these shares. Dr. James I. Healy and Dr. Maha Katabi, the managing members of SM X LLC, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
/s/ Nathalie Auber, Attorney-in-Fact
2023-06-20